Multiple sclerosis (MS) is a putative autoimmune disease of the central nervous system
(CNS) in which autoreactive immune cells recognizing myelin antigens lead to …

Multiple sclerosis (MS) is a neurodegenerative condition of the central nervous system
(CNS) that presents with varying levels of disability in patients, displaying the significance of …

Teriflunomide, the active metabolite of an approved antirheumatic drug, is an emerging oral
therapy for multiple sclerosis (MS). Next to the inhibition of pyrimidine biosynthesis and …

Multiple sclerosis (MS) is an autoimmune inflammatory condition affecting the central
nervous system, and experimental autoimmune encephalomyelitis (EAE) animal models …

The present study aimed to evaluate the therapeutic potential of a mushroom extract from
Phellinus igniarius in an animal model of multiple sclerosis. The medicinal mushroom …

Multiple sclerosis (MS) is a chronic inflammatory demyelinating and neurodegenerative
disease of the central nervous system characterized by unpredictable and variable clinical …

Pathogenic T cells of multiple sclerosis (MS) patients have been suggested to be endowed
with an increased resistance to apoptosis, contributing to their increased survival. We report …

Im Jahr 2011 wurden die Ergebnisse einer Reihe interessanter klinischer Phase II und III
Studien bei Patienten mit schubförmiger Multipler Sklerose (MS) vorgestellt oder publiziert …

Multiple Sclerosis (MS) is an immune mediated disease of the central nervous system
characterized by the destruction of myelin sheaths surrounding nerve axons, and it is the …

The course of Multiple Sclerosis (MS), a chronic autoimmune disease, can be influenced by
systemic infections. The common notion is that bacterial infections worsen disease …